Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of cell division protein kinase 4 claimed

Nov. 30, 2010

New inhibitors of dual specificity protein kinase TTK patented

Nov. 30, 2010

CXR-1002 shows promising safety and antitumor activity in first-in-human trial in advanced cancer

Nov. 30, 2010

New apoptosis-inducing molecules discovered

Nov. 30, 2010

Profectus BioSciences divulges new NF-kappa-B inhibitors

Nov. 29, 2010

New inhibitors of E-selectin and chemokine CXCR4 receptor claimed

Nov. 29, 2010

SAR-153192 suppresses tumor growth in vivo and continues evaluation in phase I trial

Nov. 29, 2010

New oxalato complexes of platinum disclosed for treatment of cancer

Nov. 26, 2010

First-in-human data presented on RO-5126766 in advanced/metastatic solid tumors

Nov. 26, 2010

Tragara advances multikinase inhibitor SB-1317 to phase I trial

Nov. 25, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...